Adaptive Biotechnologies
Technology
Company overview
Adaptive Biotechnologies studies the body's immune system to build tests and treatments. Its customers include doctors, hospitals, and drug companies running clinical trials. The clonoSEQ MRD Test is a highly sensitive test that checks for remaining cancer cells after treatment. The Immune Medicine Platform gives researchers detailed immune data to help develop new medicines. Adaptive Biotechnologies is based in Seattle, United States. Historically, the median salary is ~$165,000. Adaptive Biotechnologies is an H-1B sponsor.
- Industry
- Technology
- Headquarters
- Seattle, United States